- For use in controlled laboratory conditions only
A study can describe an experimental model, but a product listing should not turn that model into a claim about a research material
Pink Sheet spoke with Empower General Counsel and Chief Compliance Officer Edgar Gonzalez about the regulatory questions compounders still have heading into the vote On the Peptides for Women podcast, Senior Director, Medical Affairs, Jean Cunningham, PharmD, BCPS, unpacked what patients should know before starting peptide therapy And on the Gladden Longevity podcast, founder and CEO Shaun Noorian talked quality standards and where peptides fit into the future of GLP-1s Swipe through for the highlights
No combining peptide from multiple vials into a single container violates sterile technique and exponentially increases contamination risk
Tesamorelin is also a peptide, but it belongs to a different class and has the potential to treat a host of concerns
When cagrilintide becomes available, discuss with your physician whether its right for your goals and tolerance profile
